H., Wang, T.-Y., Yang, Y
Intra-Abdominal Hypertension and the Abdominal Compartment Syndrome
YACAWYCH: And so it's very challenging, we think, right now to be able to separate these side effects, like nausea, from GLP-1's intended effects, like weight loss
Day and colleagues were the first group to use a series of modifications to the C-terminal portion of the glucagon sequence to increase GLP-1R potency, combined with PEGylation to generate two PEGylated peptides with adequate co-agonist properties, one unbalanced towards GLP-1R, and the other a near-balanced agonist at both GLP-1R and GCGR
Obesity multiplies risk across nearly every major cause of death
Doi: McKinley S, Andrew T, Morita M, Willoughby D